Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Men participating in assisted reproductive technology treatments will be recruited to a study involving filling erectile function questionnaires throughout fertility treatments, pregnancy and up to 1 year after birth.
Men participating in fertility will be recruited to a study involving filling erectile function questionnaires throughout fertility treatments, pregnancy and up to 1 year after birth. In addition, participants will be questioned regarding marital life, sexual intercourse frequency, medical history and treatments for erectile dysfunction in relevant cases. Thes control group will be comprised of male subjects who did not require fertility treatments to conceive.
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
| Label | Type | Description | Intervention Names |
|---|---|---|---|
| Fertility treatments | Men participating in fertility treatments. |
| |
| Spontaneous pregnancy | Men whose wives conceived spontaneously. |
|
| Name | Type | Description | Arm Group Labels | Other Names |
|---|---|---|---|---|
| Questionnaire and personal interviews. | Other | Questionnaire and personal interviews. |
|
| Measure | Description | Time Frame |
|---|---|---|
| Changes in International index of erectile function score | Changes in International index of erectile function score with a possible score ranging from 0 to 75. The higher the score, the better erectile function is. | From recruitment up to 3 years. |
| Measure | Description | Time Frame |
|---|---|---|
| Sexual intercourse rate. | Sexual intercourse rate as measured by the average monthly intercourse rate. | From recruitment up to 3 years. |
| Use of phospho-di-esterase 5 inhibitors | Use of phospho-di-esterase 5 inhibitors as measured by the number of men using this medication. |
Not provided
Inclusion Criteria:
Exclusion Criteria:
Male
Male patients participating in fertility treatments.
Not provided
| Name | Affiliation | Role |
|---|---|---|
| Roy Lauterbach, MD | Rambam healthcare campus | Principal Investigator |
| Facility | Status | City | State | ZIP | Country | Contacts |
|---|---|---|---|---|---|---|
| Rambam healthcare campus | Haifa | Israel |
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
| ID | Term |
|---|---|
| D007172 | Erectile Dysfunction |
| ID | Term |
|---|---|
| D005832 | Genital Diseases, Male |
| D000091662 | Genital Diseases |
| D000091642 | Urogenital Diseases |
| D012735 | Sexual Dysfunction, Physiological |
Not provided
Not provided
| ID | Term |
|---|---|
| D011795 | Surveys and Questionnaires |
| ID | Term |
|---|---|
| D003625 | Data Collection |
| D004812 | Epidemiologic Methods |
| D008919 | Investigative Techniques |
| D017531 | Health Care Evaluation Mechanisms |
Not provided
Not provided
Not provided
Not provided
Not provided
| From recruitment up to 3 years. |
| D052801 | Male Urogenital Diseases |
| D020018 | Sexual Dysfunctions, Psychological |
| D001523 | Mental Disorders |
| D011787 | Quality of Health Care |
| D017530 | Health Care Quality, Access, and Evaluation |
| D011634 | Public Health |
| D004778 | Environment and Public Health |